NCT06344832
SSTR PET/CT for Preoperative N Stage Evaluation in GEP-NETs
Not Yet Recruiting · Not specified · Peking Union Medical College Hospital · registry updated 2024-04-03
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
The research aims to prospectively include patients with GEP-NENs, undergo preoperative imaging assessment (including PET/CT and contrast-enhanced CT), and accurately delineate lymph node regions. Through postoperative pathological reports, the diagnostic performance of lymph node metastasis (LNM) in GEP-NENs is evaluated. Factors influencing the diagnostic accuracy of SSTR-PET/CT and contrast-enhanced CT are also investigated.
Inclusion
- Age \> 18 years old;
- Patients diagnosed with GEP-NEN by surgical pathology;
- Complete medical records including basic information and treatment process;
- Patients who have undergone preoperative contrast-enhanced CT and 68Ga-SSTR-PET/CT, and have consented to the 68Ga-SSTR-PET/CT project in the Nuclear Medicine Department.
Exclusion
- Presence of concomitant malignancies;
- Cases diagnosed pathologically as non-GEP-NEN.